Digital CMC offers significant opportunities for the pharmaceutical and biotech industries to enhance operational efficiency, improve regulatory compliance, and speed up time-to-market. By adopting ...

Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an ...

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and ...

Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

Senhwa Biosciences raises $16M to advance AI-powered drug discovery, accelerate cancer treatment trials, and expand machine ...

Fierce Biotech has released its annual ranking of the top 10 pharma R&D budgets of 2025—offering a clear look at which ...

MaaT Pharma secures important funding in line with one of the goals under the Health Innovation 2030 Plan, the health component of 'France 2030', led by the Health Innovation Agency dedicated to ...

Novo Nordisk and Novartis deepened their ties to AI companies on Tuesday.

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including ...

Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...